i.Bioceuticals
i.Bioceuticals is the exclusive North American B2B supplier of MASQUELIER's OPCs ingredients (grape seed and French maritime pine bark extracts) to brand manufacturers and GMP manufacturers in the nutritional supplement, pharmaceutical, and functional food industries.
- Company typePrivate
- Founded1994
- HeadquartersOrleans, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What i.Bioceuticals does
i.Bioceuticals, Inc. is a privately held B2B specialty ingredient supplier headquartered in Orleans, Massachusetts. The company holds exclusive North American distribution rights to MASQUELIER's Original OPCs (oligomeric proanthocyanidins derived from Vitis vinifera grape seeds) and MASQUELIER's French Pine Bark Extract (sourced from Pinus maritima bark in southwest France), operating under a long-standing partnership with I.N.C. that has spanned more than 20 years. The company serves brand manufacturers, GMP manufacturers, and finished-product formulators in the nutritional supplement, pharmaceutical, and functional food industries who require authenticated, trademark-licensed OPCs ingredients with documented quality and regulatory substantiation.
The technical foundation rests on Professor Jack Masquelier's original 1948 industrial methods for isolating OPCs and the proprietary Complex Phytonutrient Authentication (CPA) system, which combines DNA barcoding of source seeds, batch-file tracking during extraction, and Nuclear Magnetic Resonance plus Principal Component Analysis testing of finished material. Manufacturing occurs in France under pharmaceutical-grade regulations in an ISO 9002-certified facility, with screening against over 200 pesticides and verification of consistent ratios across 29 distinct OPC molecules. This authentication infrastructure supports seven FDA-aligned structure/function claim categories covering cardiovascular, collagen, antioxidant, sports recovery, anti-aging, leg veins, and eye health.
Commercially, i.Bioceuticals operates a consultative, sales-led B2B motion: pricing is not publicly disclosed, and customers engage directly to receive Technical Specification Sheets, Certificates of Analysis, Material Safety Data Sheets, and a Full Traceability Dossier. Downstream brands must execute a trademark letter of agreement before deploying the MASQUELIER's® mark on finished product labels. The operating footprint is small (1-10 employees), revenue is undisclosed, no funding rounds or acquisitions are recorded, and the partnership with I.N.C. plus a single product family define the present scope of the business.
i.Bioceuticals firmographics
Firmographics- Name
- i.Bioceuticals
- Legal name
- i.BioCeuticals, Inc.
- Website
- https://ibioceuticals.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- i.Bioceuticals is the exclusive North American B2B supplier of MASQUELIER's OPCs ingredients (grape seed and French maritime pine bark extracts) to brand manufacturers and GMP manufacturers in the nutritional supplement, pharmaceutical, and functional food industries.
- Ownership category
- akta.pro rank
i.Bioceuticals industry classification
Industry- Product category
- Nutritional Supplement Ingredients
- NAICS
- Spice and Extract Manufacturing (311942)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts) (AFAJAFAF)
Keywords
Where i.Bioceuticals is headquartered
LocationHeadquarters
- HQ city
- Orleans
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
i.Bioceuticals business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
Revenue model
- OPCs Ingredient Supply: i.Bioceuticals operates as an exclusive North American supplier of MASQUELIER's OPCs raw material ingredients (Original OPCs and French Pine Bark Extract) to brand manufacturers, GMP manufacturers, and finished product companies in the nutritional supplement, pharmaceutical, and functional food industries.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
i.Bioceuticals product offering
Product offeringCore offering
i.Bioceuticals is the exclusive North American supplier of MASQUELIER's® Original OPCs (derived from Vitis vinifera grape seeds) and MASQUELIER's® French Pine Bark Extract (derived from Pinus Maritima maritime pine bark). The company sells these OPCs raw material ingredients to brand manufacturers and GMP manufacturers in the nutritional supplement, pharmaceutical, and functional food industries, backed by more than 70 years of scientific research and supported with technical guidance, regulatory insight, marketing consultation, and Certificates of Analysis.
Product overview
i.Bioceuticals is a B2B ingredient supplier offering two core OPCs (oligomeric proanthocyanidins) products: MASQUELIER's® Original OPCs derived from Vitis vinifera grape seeds, and MASQUELIER's® French Pine Bark Extract derived from Pinus Maritima maritime pine bark. Both products are manufactured in France under pharmaceutical regulations and are backed by over 70 years of scientific research. The company serves as the exclusive North American distributor for MASQUELIER's® branded OPCs ingredients.
Differentiator
Problem solved
Functional benefit
Products and services
- MASQUELIER's® Original OPCs OPCs (oligomeric proanthocyanidins) raw material ingredient derived from seeds of Vitis vinifera L. grapes grown in French vineyards, manufactured in France under pharmaceutical regulations in an ISO 9002 certified facility; sold to brand manufacturers and GMP manufacturers for incorporation into nutritional supplements, pharmaceuticals, and functional foods.
- MASQUELIER's® French Pine Bark Extract French Maritime Pine Bark Extract (Pinus Maritima) raw material ingredient sourced from trees in the Les Landes area of southwest France; first and most researched French pine bark extract, manufactured in France under pharmaceutical regulations and ISO 9002 quality certified. Sold to brand manufacturers and GMP manufacturers for finished product formulations targeting cardiovascular, antioxidant, and other OPCs-related health benefits.
Companies that use i.Bioceuticals
Customer profileSegments1 record
Ideal customer profiles1 record
i.Bioceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
i.Bioceuticals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- I.N.C.corei.Bioceuticals has been in partnership with I.N.C. as the exclusive North American supplier of MASQUELIER's OPCs ingredients for more than 20 years. I.N.C. grants i.Bioceuticals exclusive rights to manufacture and distribute Professor Masquelier's specific OPCs compositions throughout North America.
Scale indicators2 records
Recent moves5 records
Expansion highlights3 records
i.Bioceuticals competitors and assessment
Company assessmentBroad incumbents
- Naturex (Givaudan): French-based global leader in natural specialty ingredients (now part of Givaudan) offering plant extracts for nutraceutical, food, and personal care applications. Comparable as a large-scale botanical extract ingredient supplier with similar end-markets, though significantly broader in portfolio and scale.
- Martin Bauer Group: German-headquartered global supplier of botanical extracts, tea, and plant-based ingredients for beverages, supplements, and functional foods. Directly comparable business activity as a B2B plant extract ingredient supplier serving nutraceutical and functional food brands.
- Indena S.p.A. Major Italian botanical extracts manufacturer serving global nutraceutical, pharmaceutical, and cosmetic markets with standardized plant-derived ingredients. Directly comparable as a botanical extract ingredient supplier with established scientific substantiation and pharma-grade quality positioning.
- Frutarom (IFF Health): Acquired by International Flavors & Fragrances (IFF), Frutarom brought an extensive portfolio of botanical extracts, nutraceutical ingredients, and natural flavors serving supplement, food, and personal care manufacturers. Comparable end-markets and ingredient supplier business model, though operating at far larger scale.
Direct peers
- Nexira: French company specializing in natural plant-based ingredients (including botanical extracts and polyphenol-rich ingredients) for nutrition and health applications. Directly comparable as a botanical extract supplier with science-led positioning targeting supplement brands.
- Sabinsa Corporation: US-based botanical extracts and nutraceutical ingredients company offering branded, clinically-substantiated plant extracts to supplement and pharma manufacturers. Comparable as a science-backed branded botanical ingredients supplier with a similar B2B ingredient model.
- Euromed S.A. Spanish manufacturer of standardized botanical extracts for the nutraceutical and pharmaceutical industries, with proprietary extraction processes and clinical substantiation. Highly comparable business model to i.Bioceuticals as a branded, science-backed plant extract supplier.
- Applied Food Sciences: US-based supplier of branded, science-backed botanical and functional ingredients (including antioxidant and polyphenol-based extracts) to supplement and beverage manufacturers. Directly comparable as a niche B2B botanical extract ingredient supplier in North America.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
i.Bioceuticals compliance and trust
Trust signalCompliance1 record
i.Bioceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
i.Bioceuticals leadership team
Management profileNumber of profiles
i.Bioceuticals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
i.Bioceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about i.Bioceuticals
What does i.Bioceuticals do?
i.Bioceuticals is the exclusive North American supplier of MASQUELIER's® Original OPCs (derived from Vitis vinifera grape seeds) and MASQUELIER's® French Pine Bark Extract (derived from Pinus Maritima maritime pine bark). The company sells these OPCs raw material ingredients to brand manufacturers and GMP manufacturers in the nutritional supplement, pharmaceutical, and functional food industries, backed by more than 70 years of scientific research and supported with technical guidance, regulatory insight, marketing consultation, and Certificates of Analysis.
Is i.Bioceuticals a public or private company?
i.Bioceuticals is a private company. It is classified as unknown and is currently operating.
When was i.Bioceuticals founded?
i.Bioceuticals was founded in 1994. It employs 1 to 10 people.
Where is i.Bioceuticals based?
i.Bioceuticals is headquartered in Orleans, United States, in the North America region.
How does i.Bioceuticals make money?
One revenue line is on record: OPCs Ingredient Supply.
Who are i.Bioceuticals's main competitors?
Broad incumbents on record are Naturex (Givaudan), Martin Bauer Group, Indena S.p.A. and Frutarom (IFF Health). Direct peers are Nexira, Sabinsa Corporation, Euromed S.A. and Applied Food Sciences.
Does i.Bioceuticals have an API?
No public API is recorded for i.Bioceuticals.
What industry is i.Bioceuticals in?
i.Bioceuticals's product category is Nutritional Supplement Ingredients. Its primary akta.pro industry code is AFAJAFAF, Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts). Its NAICS code is 311942 and its SIC code is 2833.